alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Lo que usted debe saber sobre la

compra de medicamentos fuera de

los Estados Unidos

Si usted compra medicina extranjera via el internet, ó através de

un negocio que le ofrezca ordenar sus medicinas, o durante sus

visitas furera de Los Estados Unidos, usted está tomando un

riesgo. La oficina de La Administración de Drogras y Alimentos

de los Estados Unidos no puede garantizarle la seguridad de

estas medicinas.

PREOCUPACIONES SOBRE GARANTÍA DE CALIDAD. Es posible que los

medicamentos cuya venta no se ha aprobado en los Estados Unidos no 

se hayan elaborado siguiendo procedimientos de control de calidad 

diseñados para preparar un producto seguro y eficaz.

POSIBILIDAD DE FALSIFICACIÓN. Algunos medicamentos importados,

hasta los que llevan el nombre de un producto aprobado en Estados

Unidos, pueden ser versiones falsificadas que son peligrosas o incluso

completamente ineficaces.

PRESENCIA DE SUSTANCIAS NO VERIFICADAS. La seguridad y eficacia

de algunos medicamentos importados y sus ingredientes, aunque son

legales en el extranjero, podrían no haberse evaluado en Estados

Unidos. Estos productos pueden crear adicción o contener otras 

sustancias peligrosas.

RIESGOS DEL USO NO SUPERVISADO. Algunos medicamentos, sean

importados o no, son peligrosos si se toman sin la supervisión médica

adecuada. Tal vez necesite que le hagan una evaluación médica para

garantizar que el medicamento es adecuado para usted y para tratar 

su condición médica. O, usted puede requerir revisiones médicas para 

verificar que está tomando el medicamento adecuadamente, que le

está surtiendo efecto y que usted no está experimentando efectos

secundarios inesperados o posiblemente mortales.

ASUNTOS RELACIONADOS CON LAS ETIQUETAS Y EL IDIOMA. 

La etiqueta del medicamento, incluyendo las instrucciones de uso y 

sus posibles efectos secundarios, podría estar en un idioma que usted

no entiende y hacer afirmaciones médicas o sugerir usos específicos

cuya seguridad y eficacia no han sido evaluados adecuadamente.

FALTA DE INFORMACIÓN. Un medicamento importado podría carecer

de la información que permitiría darle un tratamiento rápido y 

apropiado en caso de que le cause un efecto secundario peligroso.

Recuerde, las medicinas que usted compra

fuera de Estados Unidos podrían ser 

peligrosas o ineficaces.

¡No vale la pena que usted 

arriesgue su salud!

Si tiene preguntas sobre el uso de cualquier medicamento, la

FDA lo alienta a comunicarse con su médico, su farmacéutico

local o Consejo Farmacéutico del estado en que usted vive.

(FDA) 04-1511AS
#### § 317.308 Labeling of meat or meat food products with number of servings.

The label of any package of a meat or meat food product that bears a representation as to the number of servings contained in such package shall meet the requirements of § 317.2(h)(10).

[58 FR 664, Jan. 6, 1993, as amended at 60 FR 176, Jan. 3, 1995]
### §2226. Dissemination of fire prevention and control information

The Administrator of FEMA, acting through the Administrator, is authorized to take steps to encourage the States to promote the use of automatic sprinkler systems and automatic smoke detection systems, and to disseminate to the maximum extent possible information on the life safety value and use of such systems. Such steps may include, but need not be limited to, providing copies of the guidelines described in section 2225 of this title and of the master list compiled under section 2224(b) of this title to Federal agencies, State and local governments, and fire services throughout the United States, and making copies of the master list compiled under section 2224(b) of this title available upon request to interested private organizations and individuals.

(Pub. L. 93–498, §30, as added Pub. L. 101–391, §3(a), Sept. 25, 1990, 104 Stat. 748; amended Pub. L. 112–239, div. A, title XVIII, §1802(b)(1), Jan. 2, 2013, 126 Stat. 2100.)

#### **Editorial Notes**

#### Amendments

2013—Pub. L. 112–239 substituted "Administrator of FEMA" for "Director".

#### **Statutory Notes and Related Subsidiaries**

#### Transfer of Functions

For transfer of all functions, personnel, assets, components, authorities, grant programs, and liabilities of the Federal Emergency Management Agency, including the functions of the Under Secretary for Federal Emergency Management relating thereto, to the Federal Emergency Management Agency, see section 315(a)(1) of Title 6, Domestic Security.

For transfer of functions, personnel, assets, and liabilities of the Federal Emergency Management Agency, including the functions of the Director of the Federal Emergency Management Agency relating thereto, to the Secretary of Homeland Security, and for treatment of related references, see former section 313(1) and sections 551(d), 552(d), and 557 of Title 6, Domestic Security, and the Department of Homeland Security Reorganization Plan of November 25, 2002, as modified, set out as a note under section 542 of Title 6.
### §2621. National defense waiver

The Administrator shall waive compliance with any provision of this chapter upon a request and determination by the President that the requested waiver is necessary in the interest of national defense. The Administrator shall maintain a written record of the basis upon which such waiver was granted and make such record available for in camera examination when relevant in a judicial proceeding under this chapter. Upon the issuance of such a waiver, the Administrator shall publish in the Federal Register a notice that the waiver was granted for national defense purposes, unless, upon the request of the President, the Administrator determines to omit such publication because the publication itself would be contrary to the interests of national defense, in which event the Administrator shall submit notice thereof to the Armed Services Committees of the Senate and the House of Representatives.

(Pub. L. 94–469, title I, §22, Oct. 11, 1976, 90 Stat. 2044; renumbered title I, Pub. L. 99–519, §3(c)(1), Oct. 22, 1986, 100 Stat. 2989.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective Jan. 1, 1977, see section 31 of Pub. L. 94–469, set out as a note under section 2601 of this title.
### 751 5 Lemmo n Avenu e Buildin g N Bo x 145 Dallas , Texa s 7520 9 214-654-977 0 Fax 469-916-153 9 December 31 , 200 9 Mr
. Damo n Walker Transportatio n Industr

y Analys t Air Carrier Fitnes s Divisio n 1200 Ne w Jerse y Avenue , S E Washington , D C 2059 0 Dea r Mr
. Walker : W e ar e i n th e proces s o f movin g an d woul d lik e a n extensio n t o respon d t o you r request
. W e wil l includ e th e informatio n o n ou rne w Directo ro f Operation s i n ou r response , wit h ou rne w address
. Than k yo u fo ryou rcooperatio n i n thi s matter
.
Sincerely ,

Kennet h Gardne r Directo ro f Safety
Exhibit 20.1


Chase Manhattan Grantor Trust 1995-A

From: The Chase Manhattan Bank

To:   Norwest Bank Minnesota, N.A.


                   MONTHLY CERTIFICATEHOLDER'S REPORT
                   ----------------------------------

Due Period 15 Beginning Date                     11/01/1996
Due Period 15 End Date                           11/30/1996
Determination Date                               12/10/1996
Remittance Date                                  12/16/1996


I.    Monthly Principal and Principal Carryover Shortfall to Certificateholders
      (Per $1000 of Original Principal Amount)                  $ 25.2098018464

II.   Monthly Interest and Unpaid Interest to Certificateholders
      (Per $1000 of Original Principal Amount)                   $ 2.7614317577

III.  Monthly Expenses Summary

      A. Servicing Fee Disbursement                                $ 690,514.26
      B. Cash Collateral Account Expense                                 $ 0.00
      C. Total Expenses paid
         (per $1000 of Original Principal Amount)                $ 0.4602386241

IV.   Cash Collateral Account Deposit Amount                             $ 0.00

V.    Outstanding Advance Summary

      A. From Prior Period                                       $ 3,638,026.24
      B. From Current Period                                     $ 3,961,387.82
      C. Change in Amount Between Periods (Lines B - A)            $ 323,361.58

VI.   Pool Factor Information

      A. Certificate Principal Balance                         $ 790,793,849.80
      B. Initial Certificate Balance                         $ 1,500,339,658.38
      C. Pool Factor (Lines A / B)                               0.527076549222

VII.  Available Cash Collateral Account Information for Due Period

      A. Available Cash Collateral Amount                       $ 41,430,855.76
      B. Available Cash Collateral Amount Percentage            4.999999999457%

VIII. Required Cash Collateral Amount

      A. For the Current Collection Period                      $ 41,430,855.76
      B. For the Next Collection Period                         $ 39,539,692.49
# C_2007095EN.01005201.xml

| 28.4.2007 | EN | Official Journal of the European Union | C 95/52 |
| --- | --- | --- | --- |

28.4.2007

EN

Official Journal of the European Union

C 95/52

---

Action brought on 2 March 2007 — Agencja Wydawnicza Technopol v OHIM — (‘150’)

(Case T-66/07)

(2007/C 95/104)

Language of the case: Polish

Parties

Applicant: Agencja Wydawnicza Technopol, Sp. z o. o. (Częstochowa, Republic of Poland) (represented by: D. Rzążewska, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Defendant:

Form of order sought

| — | set aside in its entirety the decision delivered on 21 December 2006 by the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) in Case No R 1035/2006-4; |
| --- | --- |

—

set aside in its entirety the decision delivered on 21 December 2006 by the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) in Case No R 1035/2006-4;

| — | order the defendant to pay the costs of the proceedings. |
| --- | --- |

—

order the defendant to pay the costs of the proceedings.

Pleas in law and main arguments

Community trade mark concerned: word mark ‘150 ’for goods in Class 16

Community trade mark concerned:

Decision of the Examiner: registration refused

Decision of the Examiner:

Decision of the Board of Appeal: appeal dismissed

Decision of the Board of Appeal:

Pleas in law: incorrect application of the provisions of Article 7(1)(b) and (c) of Regulation No 40/94 on the Community trade mark (1), inasmuch as, according to the applicant, the designation ‘150’, in relation to the goods indicated, is neither descriptive nor devoid of distinctive character.

Pleas in law:

1

---

(1)  Council Regulation (EC) No 40/94 of 20 December 1993 (OJ 1994 L 11, p. 1).

1

---
§ 590.412 Approval of generic labels. ( a ) All official plants, including official plants certified under a foreign inspection system in accordance with § 590.910, may comply with the requirements in § 412.2 of this chapter.
( b ) For the purposes of § 412.2 of this chapter, an official establishment or establishment certified under a foreign inspection system includes an official plant.
[85 FR 68677, Oct. 29, 2020]
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA, 

Cross-Petitioner

v.

SHAWN AMIR HARRIS,

Respondent

:

:

:

:

:

:

:

:

:

:

:

:

No. 132 MAL 2015

Cross Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 17th day of May, 2017, the Cross Petition for Allowance of 

Appeal is DENIED.
II 

116TH CONGRESS 

2D SESSION S. 5046 

To amend the Consolidated Farm and Rural Development Act to authorize 

the contracting of functions under the Rural Business Investment Program, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 17, 2020 

Mr. BARRASSO (for Mrs. FISCHER) introduced the following bill; which was 

read twice and referred to the Committee on Agriculture, Nutrition, and 

Forestry 

A BILL 

To amend the Consolidated Farm and Rural Development 

Act to authorize the contracting of functions under the 

Rural Business Investment Program, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Rural Investment Act 

5 of 2020’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 5046 IS

1 SEC. 2. CONTRACTING OF FUNCTIONS. 

2 Subtitle H of the Consolidated Farm and Rural De3 velopment Act is amended by inserting after section 384P 

4 (7 U.S.C. 2009cc–15) the following: 

5 ‘‘SEC. 384Q. CONTRACTING OF FUNCTIONS. 

6 ‘‘(a) IN GENERAL.—Notwithstanding any other pro7 vision of law, to carry out the day-to-day management and 

8 operation of the program authorized by this subtitle on 

9 behalf of the Secretary, the Secretary shall enter into an 

10 interagency agreement under section 1535 of title 31, 

11 United States Code, with the Administrator of the Small 

12 Business Administration. 

13 ‘‘(b) FUNDING.—The costs incurred by the Adminis14 trator of the Small Business Administration under an 

15 agreement entered into under subsection (a) shall be reim16 bursed in accordance with section 1535 of title 31, United 

17 States Code, from amounts made available under section 

18 384S.’’. 

19 SEC. 3. APPROPRIATION. 

20 (a) IN GENERAL.—There is appropriated, from 

21 amounts in the Treasury not otherwise appropriated, 

22 $1,000,000,000 to carry out the Rural Business Invest23 ment Program established under subtitle H of the Consoli24 dated Farm and Rural Development Act (7 U.S.C. 2009cc 

25 et seq.). 


kjohnson on DSK79L0C42PROD with BILLS
3 

•S 5046 IS

1 (b) REQUIREMENT.—Not later than 180 days after 

2 the date of enactment of this Act, the Secretary of Agri3 culture, in coordination with the Administrator of the 

4 Small Business Administration, shall issue commitments 

5 to purchase, or to guarantee the timely payment of all 

6 principal and interest as scheduled on, debentures issued 

7 by rural business investment companies under subtitle H 

8 of the Consolidated Farm and Rural Development Act (7 

9 U.S.C. 2009cc et seq.). 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
# C_2007133EN.01001101.xml

| 15.6.2007 | EN | Official Journal of the European Union | C 133/11 |
| --- | --- | --- | --- |

15.6.2007

EN

Official Journal of the European Union

C 133/11

---

Euro exchange rates (1)

1

14 June 2007

(2007/C 133/05)

1 euro=

1 euro

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3304 |
| JPY | Japanese yen | 163,56 |
| DKK | Danish krone | 7,4461 |
| GBP | Pound sterling | 0,67605 |
| SEK | Swedish krona | 9,4166 |
| CHF | Swiss franc | 1,6549 |
| ISK | Iceland króna | 84,12 |
| NOK | Norwegian krone | 8,1075 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5835 |
| CZK | Czech koruna | 28,603 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 252,89 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6964 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 3,8236 |
| RON | Romanian leu | 3,2480 |
| SKK | Slovak koruna | 34,315 |
| TRY | Turkish lira | 1,7738 |
| AUD | Australian dollar | 1,5937 |
| CAD | Canadian dollar | 1,4202 |
| HKD | Hong Kong dollar | 10,3998 |
| NZD | New Zealand dollar | 1,7746 |
| SGD | Singapore dollar | 2,0524 |
| KRW | South Korean won | 1 237,07 |
| ZAR | South African rand | 9,6057 |
| CNY | Chinese yuan renminbi | 10,1682 |
| HRK | Croatian kuna | 7,3445 |
| IDR | Indonesian rupiah | 12 066,73 |
| MYR | Malaysian ringgit | 4,6105 |
| PHP | Philippine peso | 62,090 |
| RUB | Russian rouble | 34,6600 |
| THB | Thai baht | 43,313 |

Currency

Exchange rate

USD

US dollar

1,3304

JPY

Japanese yen

163,56

DKK

Danish krone

7,4461

GBP

Pound sterling

0,67605

SEK

Swedish krona

9,4166

CHF

Swiss franc

1,6549

ISK

Iceland króna

84,12

NOK

Norwegian krone

8,1075

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5835

CZK

Czech koruna

28,603

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

252,89

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6964

MTL

Maltese lira

0,4293

PLN

Polish zloty

3,8236

RON

Romanian leu

3,2480

SKK

Slovak koruna

34,315

TRY

Turkish lira

1,7738

AUD

Australian dollar

1,5937

CAD

Canadian dollar

1,4202

HKD

Hong Kong dollar

10,3998

NZD

New Zealand dollar

1,7746

SGD

Singapore dollar

2,0524

KRW

South Korean won

1 237,07

ZAR

South African rand

9,6057

CNY

Chinese yuan renminbi

10,1682

HRK

Croatian kuna

7,3445

IDR

Indonesian rupiah

12 066,73

MYR

Malaysian ringgit

4,6105

PHP

Philippine peso

62,090

RUB

Russian rouble

34,6600

THB

Thai baht

43,313

---

(1)

1

Source: reference exchange rate published by the ECB.

Source:

---
# C_2007117EN.01000802.xml

| 26.5.2007 | EN | Official Journal of the European Union | C 117/8 |
| --- | --- | --- | --- |

26.5.2007

EN

Official Journal of the European Union

C 117/8

---

Reference for a preliminary ruling from the Conseil d'État (France) lodged on 5 March 2007 — Société Arcelor Atlantique et Lorraine, Société Sollac Méditerranée, Société Arcelor Packaging International, Société Ugine & Alz France, Société Industeel Loire, Société Creusot Métal, Société Imphy Alloys and Société Arcelor v Premier ministre, Ministre de l'Économie, des Finances et de l'Industrie, Ministre de l'Écologie et du Développement durable

(Case C-127/07)

(2007/C 117/12)

Language of the case: French

Referring court

Conseil d'État

Parties to the main proceedings

Applicants: Société Arcelor Atlantique et Lorraine, Société Sollac Méditerranée, Société Arcelor Packaging International, Société Ugine & Alz France, Société Industeel Loire, Société Creusot Métal, Société Imphy Alloys and Société Arcelor

Applicants:

Defendants: Premier ministre, Ministre de l'Économie, des Finances et de l'Industrie, Ministre de l'Écologie et du Développement durable

Defendants:

Question referred

Is Directive 2003/87/EC of 13 October 2003 (1) valid in the light of the principle of equal treatment, in so far as that Directive makes the greenhouse gas emission allowance trading scheme applicable to installations in the steel sector without including in its scope the aluminium and plastic industries?

1

---

(1)  Directive 2003/87/EC of the European Parliament and of the Council of 13 October 2003 establishing a scheme for greenhouse gas emission allowance trading within the Community and amending Council Directive 96/61/EC (OJ L 275, p. 32).

1

---
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          32,609
<SECURITIES>                                         0
<RECEIVABLES>                                    7,447
<ALLOWANCES>                                     (360)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                42,076
<PP&E>                                           6,638
<DEPRECIATION>                                 (3,650)
<TOTAL-ASSETS>                                  56,374
<CURRENT-LIABILITIES>                           13,195
<BONDS>                                            473
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        74,375
<OTHER-SE>                                    (32,599)
<TOTAL-LIABILITY-AND-EQUITY>                    56,374
<SALES>                                         23,002
<TOTAL-REVENUES>                                23,002
<CGS>                                            7,566
<TOTAL-COSTS>                                   27,548
<OTHER-EXPENSES>                                    21
<LOSS-PROVISION>                                   360
<INTEREST-EXPENSE>                                 362
<INCOME-PRETAX>                               (12,091)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (12,091)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (12,091)
<EPS-BASIC>                                     (1.28)
<EPS-DILUTED>                                   (1.28)


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A)
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF SAGE, INC. AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH (B) 10Q FOR THE PERIOD ENDED JUNE 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          55,950
<SECURITIES>                                         0
<RECEIVABLES>                                    6,191
<ALLOWANCES>                                         0
<INVENTORY>                                      1,944
<CURRENT-ASSETS>                                   858
<PP&E>                                           6,717
<DEPRECIATION>                                   4,601
<TOTAL-ASSETS>                                 188,523
<CURRENT-LIABILITIES>                           11,313
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           141
<OTHER-SE>                                     177,069
<TOTAL-LIABILITY-AND-EQUITY>                   188,523
<SALES>                                          6,476
<TOTAL-REVENUES>                                 6,476
<CGS>                                            3,358
<TOTAL-COSTS>                                    3,358
<OTHER-EXPENSES>                                12,211
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (9,093)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (9,093)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,093)
<EPS-BASIC>                                     (0.83)
<EPS-DILUTED>                                   (0.83)


</TABLE>